{"organizations": [], "uuid": "9eb2c3066764d49c1781e9564a4c041d90e1b242", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180208.html", "section_title": "Archive News &amp; Video for Thursday, 08 Feb 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-livzon-pharmaceutical-group-to-sel/brief-livzon-pharmaceutical-group-to-sell-51-stake-in-livzon-mab-to-biologics-ltd-idUSFWN1PX0SU", "country": "US", "domain_rank": 408, "title": "BRIEF-Livzon Pharmaceutical Group To Sell 51% Stake In Livzon Mab To Biologics Ltd", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.99, "site_type": "news", "published": "2018-02-07T18:52:00.000+02:00", "replies_count": 0, "uuid": "9eb2c3066764d49c1781e9564a4c041d90e1b242"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-livzon-pharmaceutical-group-to-sel/brief-livzon-pharmaceutical-group-to-sell-51-stake-in-livzon-mab-to-biologics-ltd-idUSFWN1PX0SU", "ord_in_thread": 0, "title": "BRIEF-Livzon Pharmaceutical Group To Sell 51% Stake In Livzon Mab To Biologics Ltd", "locations": [], "entities": {"persons": [{"name": "livzon", "sentiment": "none"}], "locations": [], "organizations": [{"name": "livzon mab to biologics ltd", "sentiment": "negative"}, {"name": "brief-livzon pharmaceutical group to sell", "sentiment": "negative"}, {"name": "reuters) - livzon pharmaceutical group inc", "sentiment": "neutral"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "Feb 7 (Reuters) - Livzon Pharmaceutical Group Inc :\n* ‍APPROVED TRANSACTION IN RESPECT OF CHANGE IN SHAREHOLDING STRUCTURE OF LIVZON MABPHARM INC​\n* CO TO SELL 51% EQUITY INTERESTS IN LIVZON MAB TO BIOLOGICS LIMITED\n* ‍LIVZON INTERNATIONAL & JOINCARE BVI TO CONTRIBUTE TO LIVZON BIOLOGICS RMB306 MILLION AND RMB294 MILLION RESPECTIVELY​\n* ‍BIOLOGICS LIMITED AGREED TO ACQUIRE 49% EQUITY INTERESTS IN LIVZON MAB FROM JOINCARE​ Source text for Eikon: Further company coverage: (bangalore.newsroom@thomsonreuters.com)\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html"], "published": "2018-02-07T18:52:00.000+02:00", "crawled": "2018-02-09T05:59:01.000+02:00", "highlightTitle": ""}